Literature DB >> 23777768

IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation.

Nicole Wilkinson1, Kostas Pantopoulos.   

Abstract

Hypoxia inducible factor 2α (HIF2α) transcriptionally activates several genes in response to hypoxia. Under normoxic conditions, it undergoes oxygen-dependent degradation by the prolyl hydroxylase (PHD)/von Hippel-Lindau (VHL) system. The presence of an iron-responsive element (IRE) within the 5' untranslated region of HIF2α mRNA suggests a further iron- and oxygen-dependent mechanism for translational regulation of its expression via iron regulatory proteins 1 and 2 (IRP1 and IRP2, respectively). We show here that the disruption of mouse IRP1, but not IRP2, leads to profound HIF2α-dependent abnormalities in erythropoiesis and systemic iron metabolism. Thus, 4- to 6-week-old IRP1(-/-) mice exhibit splenomegaly and extramedullary hematopoiesis, which is corrected in older animals. These erythropoietic abnormalities are caused by translational de-repression of HIF2α mRNA and subsequent accumulation of HIF2α, which induces expression of erythropoietin (Epo). Increased levels of circulating Epo lead to reticulocytosis, polycythemia, and suppression of hepatic hepcidin mRNA. This in turn promotes hyperferremia and iron depletion in splenic macrophages due to unrestricted expression of ferroportin. Our data demonstrate that IRP1 is the principal regulator of HIF2α mRNA translation in vivo and provide evidence that translational control of HIF2α expression dominates over PHD/VHL-mediated regulation of HIF2α stability in juvenile IRP1(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23777768     DOI: 10.1182/blood-2013-03-492454

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

Authors:  De-Liang Zhang; Manik C Ghosh; Hayden Ollivierre; Yan Li; Tracey A Rouault
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

Review 2.  The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension.

Authors:  Jeffrey C Robinson; Brian B Graham; Tracey C Rouault; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2014-12       Impact factor: 6.914

Review 3.  Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.

Authors:  Manik C Ghosh; De-Liang Zhang; Tracey A Rouault
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

Review 4.  β-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies.

Authors:  Stefano Rivella
Journal:  Haematologica       Date:  2015-04       Impact factor: 9.941

5.  Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2.

Authors:  Masaki Miyazawa; Alexander R Bogdan; Yoshiaki Tsuji
Journal:  Cell Chem Biol       Date:  2018-11-15       Impact factor: 8.116

Review 6.  Hypoxia-inducible factors link iron homeostasis and erythropoiesis.

Authors:  Yatrik M Shah; Liwei Xie
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

7.  Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts.

Authors:  Huihui Li; Yutong Liu; Longcheng Shang; Jing Cai; Jing Wu; Wei Zhang; Xiaojiang Pu; Weichen Dong; Tong Qiao; Kuanyu Li
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

Review 8.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

9.  Pharmacological HIF2α inhibition improves VHL disease-associated phenotypes in zebrafish model.

Authors:  Ana Martins Metelo; Haley R Noonan; Xiang Li; Youngnam Jin; Rania Baker; Lee Kamentsky; Yiyun Zhang; Ellen van Rooijen; Jordan Shin; Anne E Carpenter; Jing-Ruey Yeh; Randall T Peterson; Othon Iliopoulos
Journal:  J Clin Invest       Date:  2015-04-13       Impact factor: 14.808

10.  Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload.

Authors:  Andrew J Schwartz; Nupur K Das; Sadeesh K Ramakrishnan; Chesta Jain; Mladen T Jurkovic; Jun Wu; Elizabeta Nemeth; Samira Lakhal-Littleton; Justin A Colacino; Yatrik M Shah
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.